FuelCell Energy Valuation
Is FCEL * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of FCEL * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate FCEL *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate FCEL *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FCEL *?
Other financial metrics that can be useful for relative valuation.
What is FCEL *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$338.14m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.5x |
Enterprise Value/EBITDA | -2.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does FCEL *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.4x | ||
ARISTOS A Consorcio Aristos. de | 3.4x | n/a | Mex$6.9b |
ELEMAT * Elementia Materiales S. A. B. de C. V | 0.6x | n/a | Mex$11.5b |
AGUA * Grupo Rotoplas. de | 1.1x | 12.1% | Mex$13.4b |
GMD * Grupo Mexicano de Desarrollo | 0.4x | n/a | Mex$2.2b |
FCEL * FuelCell Energy | 3.7x | 35.2% | Mex$338.1m |
Price-To-Sales vs Peers: FCEL * is expensive based on its Price-To-Sales Ratio (3.7x) compared to the peer average (0.8x).
Price to Earnings Ratio vs Industry
How does FCEL *'s PE Ratio compare vs other companies in the Global Electrical Industry?
Price-To-Sales vs Industry: FCEL * is expensive based on its Price-To-Sales Ratio (3.7x) compared to the Global Electrical industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is FCEL *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 3.7x |
Fair PS Ratio | 0.2x |
Price-To-Sales vs Fair Ratio: FCEL * is expensive based on its Price-To-Sales Ratio (3.7x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$12.25 | Mex$25.73 +110.1% | 21.9% | Mex$37.10 | Mex$18.55 | n/a | 7 |
Jun ’25 | Mex$15.10 | Mex$25.13 +66.4% | 24.2% | Mex$33.99 | Mex$16.99 | n/a | 7 |
May ’25 | Mex$15.69 | Mex$25.05 +59.6% | 22.8% | Mex$34.10 | Mex$17.05 | n/a | 8 |
Apr ’25 | Mex$19.50 | Mex$25.32 +29.9% | 22.7% | Mex$33.62 | Mex$16.81 | n/a | 8 |
Mar ’25 | Mex$21.00 | Mex$29.07 +38.4% | 25.3% | Mex$42.75 | Mex$17.10 | n/a | 8 |
Feb ’25 | Mex$22.00 | Mex$28.85 +31.1% | 25.3% | Mex$42.42 | Mex$16.97 | n/a | 8 |
Jan ’25 | Mex$27.45 | Mex$32.15 +17.1% | 34.8% | Mex$54.50 | Mex$17.03 | n/a | 8 |
Dec ’24 | Mex$21.80 | Mex$34.12 +56.5% | 32.8% | Mex$55.99 | Mex$17.50 | n/a | 8 |
Nov ’24 | Mex$18.90 | Mex$38.10 +101.6% | 30.7% | Mex$57.54 | Mex$17.98 | n/a | 8 |
Oct ’24 | Mex$22.00 | Mex$34.62 +57.4% | 26.1% | Mex$47.16 | Mex$17.15 | n/a | 8 |
Sep ’24 | Mex$24.40 | Mex$41.46 +69.9% | 17.6% | Mex$50.77 | Mex$25.38 | n/a | 7 |
Aug ’24 | Mex$36.08 | Mex$41.67 +15.5% | 16.7% | Mex$50.25 | Mex$25.13 | n/a | 8 |
Jul ’24 | Mex$37.50 | Mex$44.92 +19.8% | 23.4% | Mex$65.88 | Mex$25.67 | n/a | 8 |
Jun ’24 | Mex$38.50 | Mex$58.56 +52.1% | 19.5% | Mex$71.94 | Mex$35.97 | Mex$15.10 | 8 |
May ’24 | Mex$34.10 | Mex$58.56 +71.7% | 19.5% | Mex$71.94 | Mex$35.97 | Mex$15.69 | 8 |
Apr ’24 | Mex$51.00 | Mex$58.56 +14.8% | 19.5% | Mex$71.94 | Mex$35.97 | Mex$19.50 | 8 |
Mar ’24 | Mex$60.51 | Mex$64.72 +7.0% | 23.5% | Mex$93.80 | Mex$37.52 | Mex$21.00 | 9 |
Feb ’24 | Mex$71.00 | Mex$64.72 -8.8% | 23.5% | Mex$93.80 | Mex$37.52 | Mex$22.00 | 9 |
Jan ’24 | Mex$54.00 | Mex$67.01 +24.1% | 24.5% | Mex$98.22 | Mex$39.29 | Mex$27.45 | 9 |
Dec ’23 | Mex$67.37 | Mex$73.12 +8.5% | 29.7% | Mex$99.65 | Mex$39.86 | Mex$21.80 | 8 |
Nov ’23 | Mex$59.51 | Mex$73.12 +22.9% | 29.7% | Mex$99.65 | Mex$39.86 | Mex$18.90 | 8 |
Oct ’23 | Mex$70.99 | Mex$84.80 +19.5% | 23.4% | Mex$101.99 | Mex$61.20 | Mex$22.00 | 7 |
Sep ’23 | Mex$80.49 | Mex$86.81 +7.9% | 20.5% | Mex$101.28 | Mex$60.77 | Mex$24.40 | 7 |
Aug ’23 | Mex$70.23 | Mex$93.78 +33.5% | 26.3% | Mex$141.94 | Mex$60.83 | Mex$36.08 | 8 |
Jul ’23 | Mex$78.00 | Mex$93.78 +20.2% | 26.3% | Mex$141.94 | Mex$60.83 | Mex$37.50 | 8 |
Jun ’23 | Mex$80.00 | Mex$111.40 +39.3% | 12.2% | Mex$141.62 | Mex$101.16 | Mex$38.50 | 8 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.